$2.48 Billion is the total value of Avidity Partners Management LP's 83 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 34.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
BDX | Sell | BECTON DICKINSON & CO | $74,146,404 | -29.4% | 286,800 | -27.9% | 2.99% | -18.6% |
NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $73,361,250 | +16.9% | 652,100 | -2.0% | 2.95% | +34.8% |
THC | Sell | TENET HEALTHCARE CORP | $63,504,782 | -21.2% | 963,800 | -2.7% | 2.56% | -9.2% |
IDYA | Sell | IDEAYA BIOSCIENCES INC | $57,871,318 | -17.5% | 2,144,971 | -28.2% | 2.33% | -4.9% |
ARVN | Sell | ARVINAS INC | $51,357,814 | -25.4% | 2,614,960 | -5.7% | 2.07% | -14.0% |
KRTX | Sell | KARUNA THERAPEUTICS INC | $48,478,103 | -49.4% | 286,700 | -35.2% | 1.95% | -41.7% |
IMVT | Sell | IMMUNOVANT INC | $45,056,884 | +13.9% | 1,173,662 | -43.7% | 1.81% | +31.4% |
ZNTL | Sell | ZENTALIS PHARMACEUTICALS INC | $42,126,000 | -36.0% | 2,100,000 | -10.0% | 1.70% | -26.3% |
SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $40,960,920 | -31.9% | 2,821,000 | -1.8% | 1.65% | -21.4% |
LLY | Sell | ELI LILLY & CO | $40,284,750 | -35.4% | 75,000 | -43.6% | 1.62% | -25.6% |
ARGX | Sell | ARGENX SEsponsored adr | $39,625,378 | -44.8% | 80,600 | -56.3% | 1.60% | -36.4% |
SGRY | Sell | SURGERY PARTNERS INC | $39,136,500 | -44.1% | 1,338,000 | -14.0% | 1.58% | -35.5% |
PCVX | Sell | VAXCYTE INC | $38,549,292 | -11.8% | 756,165 | -13.6% | 1.55% | +1.7% |
AKRO | Sell | AKERO THERAPEUTICS INC | $37,383,678 | -21.9% | 739,100 | -27.9% | 1.50% | -9.9% |
Sell | BIOHAVEN LTD | $33,433,254 | +5.5% | 1,285,400 | -3.0% | 1.35% | +21.6% | |
IMGN | Sell | IMMUNOGEN INC | $30,437,184 | -19.3% | 1,917,907 | -4.0% | 1.23% | -6.9% |
BIIB | Sell | BIOGEN INC | $29,658,954 | -40.2% | 115,400 | -33.7% | 1.19% | -31.0% |
UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $22,882,860 | -60.8% | 182,000 | -50.8% | 0.92% | -54.8% |
CVAC | Sell | CUREVAC N V | $21,282,963 | -52.5% | 3,116,100 | -27.5% | 0.86% | -45.2% |
AXSM | Sell | AXSOME THERAPEUTICS INC | $20,743,352 | -47.0% | 296,800 | -45.5% | 0.84% | -39.0% |
RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $19,393,600 | -53.3% | 544,000 | -39.6% | 0.78% | -46.2% |
PRTA | Sell | PROTHENA CORP PLC | $18,446,216 | -49.5% | 382,305 | -28.5% | 0.74% | -41.8% |
RVMD | Sell | REVOLUTION MEDICINES INC | $18,191,296 | -36.7% | 657,200 | -38.9% | 0.73% | -27.0% |
IMCR | Sell | IMMUNOCORE HLDGS PLCads | $18,071,580 | -47.6% | 348,200 | -39.4% | 0.73% | -39.5% |
Sell | ROIVANT SCIENCES LTD | $17,558,567 | +3.2% | 1,503,302 | -10.9% | 0.71% | +19.0% | |
PHAT | Sell | PHATHOM PHARMACEUTICALS INC | $16,771,401 | -39.9% | 1,617,300 | -17.0% | 0.68% | -30.8% |
VRNA | Sell | VERONA PHARMA PLCsponsored ads | $13,533,890 | -32.9% | 830,300 | -13.0% | 0.54% | -22.7% |
Sell | VENTYX BIOSCIENCES INC | $12,325,677 | -45.7% | 354,900 | -48.8% | 0.50% | -37.5% | |
NTLA | Sell | INTELLIA THERAPEUTICS INC | $11,987,142 | -25.7% | 379,100 | -4.2% | 0.48% | -14.4% |
KPTI | Sell | KARYOPHARM THERAPEUTICS INC | $11,120,084 | -25.8% | 8,298,570 | -0.9% | 0.45% | -14.3% |
XENE | Sell | XENON PHARMACEUTICALS INC | $10,979,024 | -40.8% | 321,400 | -33.2% | 0.44% | -31.7% |
PACB | Sell | PACIFIC BIOSCIENCES CALIF IN | $8,636,355 | -85.0% | 1,034,294 | -76.2% | 0.35% | -82.7% |
COLL | Sell | COLLEGIUM PHARMACEUTICAL INC | $7,826,970 | +2.9% | 350,200 | -1.1% | 0.32% | +18.4% |
ALPN | Sell | ALPINE IMMUNE SCIENCES INC | $7,525,856 | -30.8% | 657,280 | -37.9% | 0.30% | -20.3% |
KZR | Sell | KEZAR LIFE SCIENCES INC | $7,153,209 | -52.0% | 6,011,100 | -1.1% | 0.29% | -44.6% |
GRTS | Sell | GRITSTONE BIO INC | $4,702,136 | -12.8% | 2,733,800 | -1.1% | 0.19% | +0.5% |
ATEC | Sell | ALPHATEC HLDGS INC | $4,012,918 | -43.2% | 309,400 | -21.3% | 0.16% | -34.4% |
NSTG | Sell | NANOSTRING TECHNOLOGIES INC | $3,954,452 | -63.8% | 2,299,100 | -14.9% | 0.16% | -58.4% |
VERV | Sell | VERVE THERAPEUTICS INC | $3,783,529 | -77.0% | 285,334 | -67.5% | 0.15% | -73.6% |
CMPX | Sell | COMPASS THERAPEUTICS INC | $3,151,212 | -38.8% | 1,599,600 | -1.3% | 0.13% | -29.4% |
ALT | Sell | ALTIMMUNE INC | $3,015,740 | -27.2% | 1,159,900 | -1.2% | 0.12% | -16.6% |
SCYX | Sell | SCYNEXIS INC | $3,008,332 | -41.3% | 1,319,444 | -24.1% | 0.12% | -32.4% |
IPSC | Sell | CENTURY THERAPEUTICS INC | $2,197,000 | -37.4% | 1,098,500 | -1.1% | 0.09% | -28.5% |
NUVBWS | Sell | NUVATION BIO INC*w exp 07/07/202 | $8,954 | -40.2% | 89,543 | -1.1% | 0.00% | -100.0% |
Exit | ARTERIS INC | $0 | – | -75,500 | -100.0% | -0.02% | – | |
Exit | EXSCIENTIA PLCads | $0 | – | -127,600 | -100.0% | -0.03% | – | |
BHC | Exit | BAUSCH HEALTH COS INC | $0 | – | -215,100 | -100.0% | -0.06% | – |
SLP | Exit | SIMULATIONS PLUS INC | $0 | – | -45,900 | -100.0% | -0.07% | – |
DNLI | Exit | DENALI THERAPEUTICS INC | $0 | – | -282,752 | -100.0% | -0.29% | – |
ETNB | Exit | 89BIO INC | $0 | – | -526,376 | -100.0% | -0.35% | – |
NARI | Exit | INARI MED INC | $0 | – | -175,000 | -100.0% | -0.36% | – |
MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -3,790,000 | -100.0% | -0.44% | – |
Exit | MINERALYS THERAPEUTICS INC | $0 | – | -766,700 | -100.0% | -0.46% | – | |
Exit | 2SEVENTY BIO INC | $0 | – | -1,342,000 | -100.0% | -0.47% | – | |
PNT | Exit | POINT BIOPHARMA GLOBAL INC | $0 | – | -1,671,800 | -100.0% | -0.53% | – |
Exit | ACELYRIN INC | $0 | – | -750,000 | -100.0% | -0.55% | – | |
PLRX | Exit | PLIANT THERAPEUTICS INC | $0 | – | -916,600 | -100.0% | -0.58% | – |
AXNX | Exit | AXONICS INC | $0 | – | -379,700 | -100.0% | -0.67% | – |
EDIT | Exit | EDITAS MEDICINE INC | $0 | – | -3,000,000 | -100.0% | -0.86% | – |
BAX | Exit | BAXTER INTL INC | $0 | – | -604,700 | -100.0% | -0.96% | – |
VIR | Exit | VIR BIOTECHNOLOGY INC | $0 | – | -1,425,000 | -100.0% | -1.22% | – |
PFE | Exit | PFIZER INC | $0 | – | -1,117,467 | -100.0% | -1.43% | – |
APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -468,700 | -100.0% | -1.49% | – |
ABC | Exit | AMERISOURCEBERGEN CORP | $0 | – | -300,000 | -100.0% | -2.02% | – |
BIO | Exit | BIO RAD LABS INCcl a | $0 | – | -152,600 | -100.0% | -2.02% | – |
ABBV | Exit | ABBVIE INC | $0 | – | -518,400 | -100.0% | -2.44% | – |
Exit | GE HEALTHCARE TECHNOLOGIES I | $0 | – | -1,045,400 | -100.0% | -2.97% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
NEUROCRINE BIOSCIENCES INC | 15 | Q3 2023 | 4.6% |
ARVINAS INC | 14 | Q3 2023 | 4.9% |
ZENTALIS PHARMACEUTICALS INC | 14 | Q3 2023 | 4.8% |
SYNDAX PHARMACEUTICALS INC | 14 | Q3 2023 | 3.2% |
IDEAYA BIOSCIENCES INC | 13 | Q3 2023 | 2.5% |
NATERA INC | 13 | Q3 2023 | 1.9% |
ALPINE IMMUNE SCIENCES INC | 13 | Q3 2023 | 0.5% |
ABBVIE INC | 12 | Q2 2023 | 9.7% |
HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 3.4% |
AVANTOR INC | 11 | Q1 2023 | 6.0% |
View Avidity Partners Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Adicet Bio, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
ALPINE IMMUNE SCIENCES, INC. | February 14, 2023 | 1,888,887 | 4.0% |
ESSA Pharma Inc. | February 14, 2023 | 1,855,400 | 4.2% |
Gritstone bio, Inc. | February 14, 2023 | 2,859,971 | 3.3% |
IVERIC bio, Inc. | February 14, 2023 | 838,407 | 0.6% |
ONCOSEC MEDICAL IncSold out | February 14, 2023 | 0 | 0.0% |
PhaseBio Pharmaceuticals Inc | February 14, 2023 | 2,040,000 | 4.1% |
Phathom Pharmaceuticals, Inc. | February 14, 2023 | 1,900,000 | 4.6% |
Viridian Therapeutics, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
Anika Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Avidity Partners Management LP's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
SC 13G | 2024-04-09 |
SC 13G | 2024-03-27 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
SC 13G/A | 2024-02-13 |
View Avidity Partners Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.